Concentrix (CNXC) Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Concentrix in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNXC shares.
View CNXC analyst ratings or view top-rated stocks.

5 Wall Street analysts have issued 12-month price objectives for Concentrix's stock. Their CNXC share price forecasts range from $70.00 to $165.00. On average, they anticipate the company's stock price to reach $120.60 in the next year. This suggests a possible upside of 65.2% from the stock's current price.
View analysts price targets for CNXC or view top-rated stocks among Wall Street analysts.

Concentrix's stock was trading at $133.16 at the start of the year. Since then, CNXC stock has decreased by 45.2% and is now trading at $73.00.
View the best growth stocks for 2023 here.

Concentrix saw a decline in short interest in August. As of August 31st, there was short interest totaling 1,700,000 shares, a decline of 15.8% from the August 15th total of 2,020,000 shares. Based on an average daily trading volume, of 428,100 shares, the short-interest ratio is currently 4.0 days. Currently, 3.9% of the shares of the stock are sold short.
View Concentrix's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, September 27th 2023.
View our CNXC earnings forecast.

Concentrix will be holding an earnings conference call on Wednesday, September 27th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

Concentrix Co. (NASDAQ:CNXC) released its earnings results on Wednesday, June, 28th. The company reported $2.69 earnings per share for the quarter, missing the consensus estimate of $2.75 by $0.06. The business had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.66 billion. Concentrix had a trailing twelve-month return on equity of 19.99% and a net margin of 5.85%. The business's revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.74 EPS.

Concentrix announced a quarterly dividend on Wednesday, June 28th. Shareholders of record on Friday, July 28th will be paid a dividend of $0.275 per share on Tuesday, August 8th. This represents a $1.10 annualized dividend and a yield of 1.51%. The ex-dividend date is Thursday, July 27th.
Read our dividend analysis for CNXC.

ETFs with the largest weight of Concentrix (NASDAQ:CNXC) stock in their portfolio include Invesco S&P Spin-Off ETF (CSD), First Trust Technology AlphaDEX Fund (FXL), Thrivent Small-Mid Cap ESG ETF (TSME), First Trust Mid Cap Value AlphaDEX Fund (FNK) and Nuveen ESG Small-Cap ETF (NUSC).Pacer US Cash Cows Growth ETF (BUL).

Concentrix (NASDAQ:CNXC) pays an annual dividend of $1.10 per share and currently has a dividend yield of 1.50%. The dividend payout ratio is 15.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNXC will have a dividend payout ratio of 9.46% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNXC.

Concentrix updated its FY 2023 earnings guidance on Thursday, June, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $6.58 billion-$6.64 billion, compared to the consensus revenue estimate of $6.21 billion.

(CNXC) raised $75 million in an IPO on Wednesday, July 1st 2015. The company issued 5,000,000 shares at a price of $15.00 per share. BofA Merrill Lynch, Wells Fargo Securities, Citigroup, Jefferies, Scotia Howard Weil, Credit Suisse, J.P. Morgan, Evercore ISI, BB&T Capital Markets, Goldman, Sachs, The Huntington Investment Company, Stifel and Nomura acted as the underwriters for the IPO and Clarksons Platou Securities, Cowen and Company and Tuohy Brothers were co-managers.

Concentrix trades on the NASDAQ under the ticker symbol "CNXC."

Concentrix's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.13%), Capital International Investors (6.08%), Impactive Capital LP (4.80%), Dimensional Fund Advisors LP (2.63%), State Street Corp (2.30%) and Silvercrest Asset Management Group LLC (1.59%). Insiders that own company stock include Andre S Valentine, Ann F Vezina, Cormac J Twomey, Dennis Polk, Jane Fogarty, Kathryn Hayley, Matthew J Cox, Matthew Miau, Richard Rosso and Star Developments Ltd Silver.
View institutional ownership trends.

Shares of CNXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CNXC stock can currently be purchased for approximately $73.00.

Concentrix (NASDAQ:CNXC) has a market capitalization of $3.80 billion and generates $6.32 billion in revenue each year. The company earns $435.05 million in net income (profit) each year or $7.24 on an earnings per share basis.

The company employs 315,000 workers across the globe.

The official website for the company is www.concentrix.com. The company can be reached via phone at 800-747-0583 or via email at david.stein@concentrix.com.